Bioavailability of LY03004 and Risperdal® Consta®

NCT02091388 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: LY03004
DRUG: Risperdal® Consta®

Sponsor

Luye Pharma Group Ltd.